Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $34.2650 (-1.82%) ($34.2650 - $34.2650) on Thu. Jun. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.32% (three month average) | RSI | 56 | Latest Price | $34.2650(-1.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.1% a day on average for past five trading days. | Weekly Trend | HALO advances 0.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(39%) IWM(34%) IWO(34%) SDY(34%) IWN(33%) | Factors Impacting HALO price | HALO will decline at least -1.66% in a week (0% probabilities). EDOC(-19%) IGOV(-14%) TBT(-12%) BNDX(-11%) UUP(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.66% (StdDev 3.32%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $33.98(0.84%) | 10 Day Moving Average | $33.45(2.44%) | 20 Day Moving Average | $33.54(2.16%) | To recent high | -20.3% | To recent low | 13.6% | Market Cap | $4.683b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |